Drug intelligence / Profile preview

ReGen-GF

Development stage: Unknown
Lead developer: Hydrafacial
Modality: Recombinant Proteins and Enzymes, Peptides
Administration: Topical

Overview

ReGen-GF is a skin-rejuvenating booster designed for use with the HydraFacial MD delivery system. It utilizes a proprietary blend of bio-engineered growth factors, known as M-007 technology, which are intended to restore skin health and diminish the appearance of fine lines and wrinkles. These growth factors act as signaling molecules that stimulate cellular repair, collagen production, and elastin synthesis within the dermal layers. Developed by Edge Systems (The Beauty Health Company), ReGen-GF is primarily used in professional aesthetic treatments to improve skin texture, tone, and overall firmness.

Brand names: ReGen-GF
Other names: HydraFacial ReGen-GF Booster

Beyond the preview

Go deeper on ReGen-GF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReGen-GF.

Explore the full profile